Korro Bio

View the org chart displaying its 13 main executives

Most searched biographies at Korro Bio

• Ram Aiyar, Chief Executive Officer and Director
• Rachel Meyers, Director
• Ali Behbahani, Director

Popular executive movements at Korro Bio

• Rachel Meyers has joined the company as Director  (posted on November 29 2023).

Create your alert
to follow the executive moves at Korro Bio.

Korro Bio has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Korro Bio

• Korro Announces $70 Million Private Placement – Korro BioBack ButtonSearch IconFilter Icon
• Korro to Participate in Upcoming Investor Conferences – Korro BioBack ButtonSearch IconFilter Icon
• Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress – Korro Bio
• Korro to Present at the TD Cowen 44th Annual Health Care Conference – Korro BioBack ButtonSearch IconFilter Icon
• Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio – Korro Bio
• Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference – Korro Bio
• Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD) – Korro Bio
• Korro Bio Appoints Dr. Rachel Meyers to Board of Directors – Korro BioBack ButtonSearch IconFilter Icon
• Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million – Korro Bio
• Korro Bio Announces Appointment of Tim Pearson to Board of Directors Upon Closing of the Proposed Merger and Promotion of Todd Chappell to Chief Operating Officer – Korro Bio
• View more press releases Close

Social media about Korro Bio

• Korro Bio on Wikipedia, Google News & Yahoo Finance
• Korro Bio on LinkedIn, Twitter & YouTube

Contact by email its executives including Ram Aiyar

Call Korro Bio at +1 857...

View the org chart

Register to receive your alert

Report an error